Karyopharm Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Karyopharm Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Karyopharm Therapeutics Inc
Rating: 1.87666675
Author: Trendlyne DVM scores

about

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and oth...

8.77 0.46 (5.54%)

140.27% Gain from 52W Low

229.8K

XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Karyopharm Therapeutics Inc is on 12 May 2026 for the purpose of Karyopharm Therapeutics Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

14.7 / 100

Technically Moderately Bullish

60.4 / 100

1Yr Price target upside is 41%

6 analysts

Karyopharm Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Karyopharm Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and oth...

140.27% Gain from 52W Low

SWOT Analysis

Karyopharm Therapeutics Inc Live Price Chart